An investigative report uncovers little recognized and unpoliced potential conflicts of interest among those who serve on FDA advisory panels that review drugs. FDA may also have missed or judged insignificant financial ties physicians had before their service on the drug approval advisory panels.
An instructor at the University of Washington set off a major debate there and elsewhere over his recent essay in which he says that the low proportion of women in computer science is at this point largely a result of women's choices and is unlikely to change. University officials immediately disputed his claims.
Wide Racial Gaps Persist in College Degree Attainment
Compared to White adults in the United States, Black adults are two-thirds as likely to hold a college degree and Latino adults are only half as likely – with both groups attaining degrees at a lower rate in 2016 than White adults did back in 1990, according to a new report by The Education Trust.
U.S. Legislators Back Larger Facilities Budget for NSF
Spending bills would boost construction account without cutting research grants, marking the second year that lawmakers have rejected President Donald Trump’s plans for the agency, which called for deep cuts in 2018 and flat funding in 2019.
Trump's NASA Chief Changed His Mind on Climate Change. He Is a Scientific Hero.
When asked why he changed his mind, Bridenstine told The Washington Post, "I heard a lot of experts, and I read a lot. I came to the conclusion myself that carbon dioxide is a greenhouse gas, that we've put a lot of it into the atmosphere, and therefore we have contributed to the global warming that we've seen."
New Cancer Treatments Lie Hidden Under Mountains of Paperwork
The National Cancer Institute has invested millions of dollars into determining the genetic sequences of patients’ tumors, and researchers have found thousands of genes that seem to drive tumor growth. But until patients’ medical records are linked to the genetic data, life-or-death questions cannot be answered.
Billionaires Are Rushing into Biotech. Inequality Is Following Them into Science
In this era of billionaires and unequal funding, where is research going? And perhaps more importantly, how will our changing resources affect the training, success, and diversity of the scientists of our future?
Michael Eisen Takes on Eric Lander and the Scientific Establishment
Michael Eisen is anything but silent. In his career as a scientist, which has included a slapdash U.S. Senate campaign, blog posts, and nearly 39,000 tweets, he has lobbed grenades at the powers that be.